Active	Status	Sponsor type	Region	Phase	Filter
7 Active 0 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rhoads, Jamie
BRAVE-AA-PEDS, NCT05723198: A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata	Recruiting	3	595	Europe, Canada, Japan, US, RoW	Baricitinib, LY3009104, Placebo	Eli Lilly and Company	Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases, Skin Diseases, Pathological Conditions, Anatomical	09/24	08/29
NCT05625633: Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts	Recruiting	2/3	120	US	Human Papillomavirus 9-valent Vaccine, Recombinant, Gardasil 9, 9-valent Gardasil, Normal Saline	Western Institute for Veterans Research, University of Utah, Merck Sharp & Dohme LLC	Warts	12/25	12/26
AMETHYST, NCT05531565 / 2020-000727-40: A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus	Recruiting	2/3	474	Europe, Canada, Japan, US, RoW	Litifilimab, BIIB059, Placebo	Biogen, Biogen Idec Research Limited	Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus	10/26	12/27
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC	Recruiting	N/A	15000	Europe, Canada, US		Target PharmaSolutions, Inc.	Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria	12/50	12/50
Klein, Stephanie Z
NCT05625633: Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts	Recruiting	2/3	120	US	Human Papillomavirus 9-valent Vaccine, Recombinant, Gardasil 9, 9-valent Gardasil, Normal Saline	Western Institute for Veterans Research, University of Utah, Merck Sharp & Dohme LLC	Warts	12/25	12/26
NCT04924036: Qbrexza Cloths for Hyperhidrosis of Amputation Sites	Completed	2	14	US	glycopyrronium cloths, Qbrexza Cloths, Placebo	University of Utah	Amputation, Hyperhidrosis	12/23	12/23
Nicholson, Lowell
NCT05625633: Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts	Recruiting	2/3	120	US	Human Papillomavirus 9-valent Vaccine, Recombinant, Gardasil 9, 9-valent Gardasil, Normal Saline	Western Institute for Veterans Research, University of Utah, Merck Sharp & Dohme LLC	Warts	12/25	12/26